(Q34725978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Quasar Collaborative Group

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Richard Gray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jennifer Barnwell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Christopher McConkey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Norman S Williams

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David J Kerr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

2020-2029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

5-Fluorouracil and folinic acid: interesting biochemistry or effective treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Development of a disease specific questionnaire to supplement a generic tool for QoL in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Management of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Review of determinants of patients' preferences for adjuvant therapy in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961866-2

7 January 2021

10.1016/S0140-6736(07)61866-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18083404%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference